Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Change in Accured Expenses (2024 - 2025)

Profound Medical (PROF) has 2 years of Change in Accured Expenses data on record, last reported at $40000.0 in Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 93.81% year-over-year to $40000.0; the TTM value through Dec 2025 reached $378000.0, down 53.62%, while the annual FY2025 figure was $378000.0, 53.62% down from the prior year.
  • Change in Accured Expenses reached $40000.0 in Q4 2025 per PROF's latest filing, up from -$207000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $676000.0 in Q3 2024 and bottomed at -$570000.0 in Q1 2024.